These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 26808812)
1. Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo. Slivicki RA; Ali YO; Lu HC; Hohmann AG PLoS One; 2016; 11(1):e0147620. PubMed ID: 26808812 [TBL] [Abstract][Full Text] [Related]
2. Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity. Yan T; Feng Y; Zheng J; Ge X; Zhang Y; Wu D; Zhao J; Zhai Q Neurochem Int; 2010 Jan; 56(1):101-6. PubMed ID: 19778564 [TBL] [Abstract][Full Text] [Related]
3. Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence. Lukacs M; Gilley J; Zhu Y; Orsomando G; Angeletti C; Liu J; Yang X; Park J; Hopkin RJ; Coleman MP; Zhai RG; Stottmann RW Exp Neurol; 2019 Oct; 320():112961. PubMed ID: 31136762 [TBL] [Abstract][Full Text] [Related]
6. Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons. Ali YO; Bradley G; Lu HC Sci Rep; 2017 Mar; 7():43846. PubMed ID: 28266613 [TBL] [Abstract][Full Text] [Related]
8. Loss-of-function approach using mouse retinal explants showed pivotal roles of Nmnat2 in early and middle stages of retinal development. Kuribayashi H; Katahira M; Aihara M; Suzuki Y; Watanabe S Mol Biol Cell; 2023 Jan; 34(1):ar4. PubMed ID: 36322391 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide Mononucleotide Adenylyltransferase 2 maintains neuronal structural integrity through the maintenance of golgi structure. Pottorf T; Mann A; Fross S; Mansel C; Vohra BPS Neurochem Int; 2018 Dec; 121():86-97. PubMed ID: 30278188 [TBL] [Abstract][Full Text] [Related]
10. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833 [TBL] [Abstract][Full Text] [Related]
11. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2. Yamagishi Y; Tessier-Lavigne M Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853 [TBL] [Abstract][Full Text] [Related]
12. CREB-activity and nmnat2 transcription are down-regulated prior to neurodegeneration, while NMNAT2 over-expression is neuroprotective, in a mouse model of human tauopathy. Ljungberg MC; Ali YO; Zhu J; Wu CS; Oka K; Zhai RG; Lu HC Hum Mol Genet; 2012 Jan; 21(2):251-67. PubMed ID: 22027994 [TBL] [Abstract][Full Text] [Related]
13. The key role of the NAD biosynthetic enzyme nicotinamide mononucleotide adenylyltransferase in regulating cell functions. Fortunato C; Mazzola F; Raffaelli N IUBMB Life; 2022 Jul; 74(7):562-572. PubMed ID: 34866305 [TBL] [Abstract][Full Text] [Related]
14. Lack of nicotinamide mononucleotide adenylyltransferase 2 (Nmnat2): consequences for mouse bladder development and function. Hicks AN; Campeau L; Burmeister D; Bishop CE; Andersson KE Neurourol Urodyn; 2013 Nov; 32(8):1130-6. PubMed ID: 23371862 [TBL] [Abstract][Full Text] [Related]
15. NMN Deamidase Delays Wallerian Degeneration and Rescues Axonal Defects Caused by NMNAT2 Deficiency In Vivo. Di Stefano M; Loreto A; Orsomando G; Mori V; Zamporlini F; Hulse RP; Webster J; Donaldson LF; Gering M; Raffaelli N; Coleman MP; Gilley J; Conforti L Curr Biol; 2017 Mar; 27(6):784-794. PubMed ID: 28262487 [TBL] [Abstract][Full Text] [Related]
16. NMNAT2: An important metabolic enzyme affecting the disease progression. Li W; Gao M; Hu C; Chen X; Zhou Y Biomed Pharmacother; 2023 Feb; 158():114143. PubMed ID: 36528916 [TBL] [Abstract][Full Text] [Related]
17. Nmnat mitigates sensory dysfunction in a Brazill JM; Cruz B; Zhu Y; Zhai RG Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716954 [TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter deficiency protects mice from mechanical allodynia and heat hyperalgesia in vincristine neuropathy. Hansen N; Uçeyler N; Palm F; Zelenka M; Biko L; Lesch KP; Gerlach M; Sommer C Neurosci Lett; 2011 May; 495(2):93-7. PubMed ID: 21419830 [TBL] [Abstract][Full Text] [Related]
19. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2. Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A Elife; 2017 Jan; 6():. PubMed ID: 28095293 [TBL] [Abstract][Full Text] [Related]
20. Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivo. Milde S; Fox AN; Freeman MR; Coleman MP Sci Rep; 2013; 3():2567. PubMed ID: 23995269 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]